De novo design seeks to generate molecules with required property profiles by virtual design-make-test cycles. With the emergence of deep learning and neural generative models in many application areas, models for molecular design based on neural networks appeared recently and show promising results. However, the new models have not been profiled on consistent tasks, and comparative studies to well-established algorithms have only seldom been performed. To standardize the assessment of both classical and neural models for de novo molecular design, we propose an evaluation framework, GuacaMol, based on a suite of standardized benchmarks. The benchmark tasks encompass measuring the fidelity of the models to reproduce the property distribution of the training sets, the ability to generate novel molecules, the exploration and exploitation of chemical space, and a variety of single and multi-objective optimization tasks. The benchmarking framework is available as an open-source Python package.
Introduction
De novo molecular design is a computational technique to generate novel compounds with desirable property profiles from scratch.
1 It complements virtual screening, where large virtual compound libraries are pre-generated, stored, and then subsequently ranked on demand.
Virtual screening has the advantage of being reasonably fast and well understood. It is particularly useful when the virtual compounds are readily available, for example in in-house screening collections, or for commercially available compounds. 2 Datasets sized on the order of 10 13 can be routinely screened under current computational constraints. 3 However, this is only a tiny fraction of chemical space, which has an estimated size anywhere between 10
24
and 10 60 possible structures. 3, 4 This number might be even larger considering new modalities such as PROTACs.
5
Efficient approaches to query larger combinatorial spaces via similarity to given structures have been reported. 6 However, it is not straightforward to perform more complex, multiobjective queries without enumerating substantial parts of the space.
In contrast, in de novo design, a relatively small number of molecules is explicitly generated, and chemical space is explored via search or optimization procedures. Thus, by focusing on the most relevant areas of chemical space for the current multi-objective query, it can in principle explore the full chemical space, given any ranking or scoring function.
In addition to established discrete models, 7 models for de novo design based on deep neural networks have been proposed in recent years, and have shown promising results.
8,9
Unfortunately, validation methods for these generative models have not been consistent.
Comparative studies to established de novo design models have not yet been performed.
Furthermore, property optimization studies often focused on easily optimizable properties, such as drug-likeness or partition coefficients. This makes it difficult to understand the strengths and weaknesses of the different models, to assess which models should be used in practice, and how they can be improved and extended further.
In other fields of machine learning, for example computer vision and natural language processing, standardized benchmarks have triggered rapid progress. 10, 11 Similarly, we believe that the field of de novo molecular design can benefit from the introduction of standardized benchmarks. They allow for a straightforward survey and comparison of existing models, and provide insight into the strengths and weaknesses of models, which is valuable information to improve current approaches.
In this work, we introduce GuacaMol, a framework for benchmarking models for de novo molecular design. We define a suite of benchmarks and implement it as a Python package designed to allow researchers to assess their models easily. We also provide implementations and results for a series of baseline models.
Models for De Novo Molecular Design
De novo design approaches require three components: 1) molecule generation, 2) a way to score the molecules, and 3) a way to optimize or search for better molecules with respect to the scoring function. 7 For scoring, any function that maps molecules to a real valued score can be used, for example quantitative structure-activity relationships (QSAR) and quantitative structure-property relationships (QSPR) models, structure-based models for affinity prediction, heuristics for the calculation of physicochemical properties, and combinations thereof for multi-objective tasks.
At the center of molecule generation and optimization strategies lies the choice of the molecular representation, which determines the potential range of exploration of chemical space. Molecules can be constructed atom-by-atom or by combination of fragments. 7 They can be grown in the context of a binding pocket, which allows for structure-based scoring, or be constructed and scored using entirely ligand-based methods. Choosing a very gen- 
16,17
Machine learning has been used in chemoinformatics for at least 50 years to score molecules (QSAR applications), that is to predict properties given a structure. 18 The inverse QSAR problem of predicting structures given target properties has received less attention.
19
However, recent advances in algorithms and hardware have made machine learning models which directly output molecular structures tractable.
16
Two early papers on generative models for molecules employed the simplified molecularinput line-entry system (SMILES) representation, which allows for the representation of molecular graphs as a string, with parentheses and numbers indicating branching points and ring closures. Figure 1 ). Figure 1 : Compounds 1-3, generated by a SMILES LSTM model, were made and tested, and showed micro-to nanomolar activity against the RXR and PPAR receptors.
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An important result about the space pretrained neural models can explore was recently published by Arus-Pous et al. They studied whether SMILES RNNs trained on a small subset (0.1%) of GDB13, an enumerated molecule set, which covers all potentially stable molecules up to 13 heavy atoms, could recover almost the full dataset after sampling a sufficient number of compounds. They showed that the SMILES RNN was able to cover (and thus explore) a large portion of the complete chemical space defined by GDB13, and even generate molecules which were incorrectly omitted in the original GDB13.
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Assessing De Novo Design Techniques
To profile models for de novo molecular design, we differentiate between their two main use cases:
• Given a training set of molecules, a model generates new molecules following the same chemical distribution.
• A model generates the best possible molecules to satisfy a predefined goal.
The collection of benchmarks we propose below assesses both facets defined here. In the following we will refer to these two categories as distribution-learning benchmarks and goaldirected benchmarks, respectively.
The two benchmark categories are evaluated independently to afford models as much flexibility as possible without penalty, since there is no one-to-one correspondence between distribution-learning and goal-directed tasks. For instance, some models are able to generate optimized molecules without learning the chemical distribution first. Also, a model able to reproduce a chemical distribution may employ different strategies to deliver optimized molecules.
Distribution-learning benchmarks
Models for de novo drug design often learn to reproduce the distribution of a training set, or use this training set to derive molecular fragments before generating targeted molecules. This allows some model architectures to learn the syntax of molecules in the selected molecular representation, and often accelerates the goal-directed tasks.
The distribution-learning benchmarks assess how well models learn to generate molecules similar to a training set. We consider five benchmarks for distribution learning:
Validity
The validity benchmark assesses whether the generated molecules are actually valid, i.e.
whether they correspond to a (at least theoretically) realistic molecule. For example, molecules with an incorrect SMILES syntax, or with invalid valence, are penalized.
Uniqueness
Given the high dimension of chemical space and the huge number of molecules potentially relevant in medicine, generative models should be able to generate a vast number of different molecules. The uniqueness benchmark assesses whether models are able to generate unique molecules -i.e., if a model generates the same molecule multiple times, it will be penalized.
Novelty
Since the ChEMBL training set represents only a tiny subset of drug-like chemical space, a model for de novo molecular design with a good coverage of chemical space will rarely generate molecules present in the training set. The novelty benchmark penalizes models when they generate molecules already present in the training set. Therefore, models overfitting the training set will obtain low scores on this task.
Fréchet ChemNet Distance
Preuer et al. introduced the Fréchet ChemNet Distance (FCD) as a measure of how close distributions of generated generated are to the distribution of molecules in the training set.
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The FCD is determined from the hidden representation of molecules in a neural network 
KL divergence
The KL (Kullback-Leibler) divergence
measures how well a probability distribution Q approximates another distribution P . For the KL divergence benchmark, the probability distributions of a variety of physicochemical descriptors for the training set and a set of generated molecules are compared, and the corresponding KL divergences are calculated. Models able to capture the distributions of molecules in the training set will lead to small KL divergence values.
It has been noted that a lack of diversity of the generated molecules is an issue for a few models for de novo design, in particular GANs. 55, 57 Other model classes do not suffer from that problem. 9 The KL divergence benchmark captures diversity to some extent, by requiring the generated molecules to be as diverse as the training set with respect to the considered property distributions.
Goal-directed benchmarks
The goal-directed optimization of molecules relies on a formalism in which molecules can be scored individually. The molecule score reflects how well a molecule fulfills the required property profile. The goal is to find molecules which maximize the scoring function.
Concretely, the models are asked to generate a given number of molecules with high scores for a given function. The models have access to the scoring function and can iteratively improve their best molecule guesses, without knowing explicitly what the scoring function calculates.
Here, by using robust and simple, but relevant scoring functions for molecular design,
we disentangle the problem of molecule optimization from the problem of choosing good scoring functions, which has been highlighted many times in the context of de novo design and virtual screening, and will not be the focus of this article.
The optimization tasks can be summarized in different categories:
Similarity
Similarity is one of the core concepts of chemoinformatics. 58 It serves multiple purposes and is an interesting objective for optimization. First, it is a surrogate for machine learning models, since it mimics an interpretable nearest neighbor model. However, it has the strong advantage over more complex machine learning (ML) algorithms that deficiencies in the ML models, stemming from training on small datasets or activity cliffs, cannot be as easily exploited by the generative models. Second, it is directly related to virtual screening: a similarity objective can be interpreted as a form of inverse virtual screening, where molecules similar to a given target compound are generated on the fly instead of looking them up in a large database. In the similarity benchmarks, models aim to generate molecules similar to a target that was removed from the training set. Models perform well for the similarity benchmarks if they are able to generate many molecules that are closely related to a given target molecule. Alternatively, the concept of similarity can be applied to exclude molecules that are too similar to other molecules.
Rediscovery
Rediscovery benchmarks are closely related to the similarity benchmarks described above.
The major difference is that the rediscovery task explicitly aims to rediscover the target molecule, not to generate many molecules similar to it.
Isomers
For the isomer benchmarks, the task is to generate molecules that correspond to a target molecular formula (for example C 7 H 8 N 2 O 2 ). The isomers for a given molecular formula can in principle be enumerated, but except for small molecules this number will in general be very large. The aim of the isomer task is not to provide a new method for generating isomers.
Instead, the isomer benchmarks assess the flexibility of the model to generate molecules following a simple pattern that is a priori unknown.
Physicochemical properties
In the physicochemical property benchmarks, the molecule scores are derived from molecular properties. Since the true properties (i.e. their experimental values) are in general not known, these benchmarks rely on values provided by computational models. Instead of pure maximization of properties, for these benchmarks we target property ranges. This corresponds more closely to typical use cases in drug design.
Median molecules
In the median molecules benchmark, ECFC4 similarity towards both Camphor and Menthol has to be maximized; it is designed to be a conflicting task. 59 Besides measuring the obtained top score, it is instructive to study if the models also explore the chemical space between the two structures.
Quantitative estimate of drug-likeness (QED)
The "quantitative estimate of drug-likeness" (QED) 60 is an empirical measure of druglikeness, similar to Lipinski's rule of 5. 61 Even though optimization of drug-likeness alone is not a particularly useful objective in drug discovery, it has been used has been used in several publications as a target for de novo molecular design (see, for instance, Refs. 8,28,41,43,51).
Multi-objective
In general, in applications of molecular design several conditions must be met at the same time in order to obtain adequate molecules. For this reason, molecular design is often a question of optimizing of the right property profile, i.e. multiple objectives are targeted instead of a single objective. The multi-objective benchmarks encompass aspects from different domains, such as:
• Structural features. Examples: molecular weight, number of aromatic rings, number of rotatable bonds;
• Physicochemical properties. Examples: TPSA, logP;
• Similarity or dissimilarity to other molecules;
• Presence and absence of functional groups or atom types.
Methods
Our framework for benchmarking models for de novo design, GuacaMol, is available as an open-source Python package and can be downloaded from the Internet. 62 GuacaMol provides user-friendly interfaces that allow researchers to couple their models to the benchmarking framework with minimal effort.
In this section, we provide the details for the generation of the datasets and the evaluation of the benchmarks. In particular, we list the five distribution-learning and the twenty goal-directed benchmarks that we propose as the first version of a suite of benchmarks for
GuacaMol.
For all chemoinformatics-related operations, such as handling or canonicalization of SMILES strings, physicochemical property (logP, TPSA) or similarity calculations, GuacaMol relies on the RDKit package.
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Dataset
Several of the molecule generation approaches we studied require a training dataset. ChEMBL 24 was used for this purpose. Furthermore, we calculate the distribution of maximum nearest neighbour similarities on ECFP4 fingerprints for both sets. Then, the distribution of these descriptors is computed via kernel density estimation (using the scipy package) for continuous descriptors, or as a histogram for discrete descriptors. The KL divergence D KL,i is then computed for each descriptor i, and is aggregated to a final score S via
where k is the number of descriptors (in our case k = 9).
Implementation details: Goal-directed benchmarks
In the goal-directed benchmarks discussed in this paper, raw molecular properties rarely correspond to the molecule scores used for optimization. Instead, they are postprocessed by modifier functions that give more flexibility in how the final molecule score is computed, and furthermore restrict scores to the interval [0, 1].
For the benchmarks discussed below, we apply different types of modifier functions:
• Gaussian(µ, σ): The Gaussian modifier allows to target a specific value of some property, while giving high scores when the underlying value is close to the target. It can be adjusted with the mean µ and standard deviation σ of the underlying Gaussian function.
• MinGaussian(µ, σ): The min Gaussian modifier corresponds to the right half of a Gaussian function. Values smaller than µ are given full score, and values larger than µ decrease continuously to zero.
• MaxGaussian(µ, σ): The max Gaussian modifier corresponds to the left half of a Gaussian function. Values larger than µ are given full score, and values smaller than µ decrease continuously to zero.
• Thresholded(t): With the thresholded modifier, full score is attributed to values above a given threshold t. Values smaller than t decrease linearly to zero.
The effect of these four modifier functions is illustrated in Figure 2 . The final benchmark score is calculated as a weighted average of the molecule scores.
For most of the benchmarks discussed below, the molecules with the best scores are given a larger weight. This choice reflects the compromise that models should be able to deliver a few molecules with top scores, but that they should also be able to generate many molecules with satisfactory scores. For all the goal-directed benchmarks, we calculate one or several average score for given numbers of top molecules, and then set the benchmark score to be the mean of these average scores. For instance, many benchmarks consider the combination of top-1, top-10 and top-100 scores, in which the benchmark score S is given by
where s is a 100-dimensional vector of molecule scores s i , 1 ≤ i ≤ 100, sorted in decreasing order (i.e., s i ≥ s j for i < j).
All the goal-directed benchmarks are listed in Table 1 . The following points give information complementary to Table 1 about our choice and implementation of the benchmarks:
• The column "Scoring" refers to the numbers of top molecules to consider in the score calculation.
• C 11 H 24 has 159 possible isomers when ignoring stereochemistry. Therefore, for this benchmark the final score is obtained from the top-159 molecule scores.
• "CNS MPO" is a benchmark on its own, but is also present as a contribution for the cobimetinib benchmark.
• "sim(x, y)" refers to a scoring function calculating the similarity to a target molecule
x. The score corresponds to the Tanimoto similarity when considering the fingerprint y and is computed with RDKit.
• "isomer(x)" refers to a scoring function for the isomer benchmarks and is detailed later in this section.
• The ranolazine MPO benchmark uses a start population, comprising one single molecule (ranolazine).
• The molecules for the pure similarity and rediscovery benchmarks are present in the holdout set considered during dataset generation.
• TPSA, logP and QED are calculated using the models contained in RDKit. 
Isomer scoring function
For the isomer benchmarks, the molecule score is calculated as an average of the following contributions:
• For each element type present in the target molecular formula: the number of atoms of this element type, modified by a Gaussian modifier. The Gaussian modifier has a mean corresponding to the target number of atoms of this element type, and a standard deviation of 1.0.
• The total number of atoms in the molecule, modified by a Gaussian modifier. The
Gaussian modifier has a mean corresponding to the total number of atoms of the target molecular formula, and a standard deviation of 2.0.
For instance, for the target formula C 11 H 24 , the score s of a molecule m is given by:
where n C (m) and n H (m) refer to the number of carbon and hydrogen atoms present in m, respectively, and n tot (m) is the total number of atoms in m.
Additional criteria
Furthermore, for each goal directed benchmark, the duration of the benchmark, the number of calls to the scoring function, and the internal similarity of the top 100 molecules are captured in the results, to allow for more fine-grained analyses.
Baselines
In addition to the introduction of a benchmark suite for generative chemistry, this paper provides its evaluation over several baselines. The goal is to present a fair comparison of some recent methods that seem to achieve state of the art results in the field. These have been selected to represent a variety of methods, ranging from deep learning generative models to the more traditional genetic algorithms and Monte Carlo Tree Search (MCTS). Internal molecule representation was also taken into account, so that methods using SMILES strings were represented alongside others using a graph representation of atoms and bonds. For completeness and to provide a lower bound on the benchmark scores, two dummy baselines, performing random sampling and best of dataset-picking, are also provided.
Our implementation of the baseline models detailed in this work are available on GitHub.
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Random sampler
This baseline simply samples the requested number of molecules from the dataset at random.
It provides a lower bound for the goal directed benchmarks as no optimization is performed to obtain the returned molecules, as well as an upper bound for two of the distribution learning benchmarks, as the molecules returned are taken directly from the original distribution.
Best in dataset
The goal of de novo molecular design is to explore unknown parts of chemical space, generating new compounds with better properties than the ones already known. This baseline simply scores the entire dataset with the provided scoring function and returns the highest scoring molecules. This effectively provides a lower bound for the goal directed benchmarks as any good de novo method should be able to generate better molecules than the ones provided during training or as a starting population. Distribution-learning benchmarks are not applicable to this baseline.
SMILES GA
Genetic algorithms (GA) for de novo molecular design are well established technique.
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Yoshikawa et al. proposed a method that evolves string molecular representations using mutations exploiting the SMILES context-free grammar. This process is repeated 1000 times or until progress has stopped for 5 consecutive epochs.
Distribution-learning benchmarks do not apply to this baseline.
Graph GA
The second genetic algorithm baseline follows the implementation of Jensen 70 in which molecule evolution happens at the graph level.
For each goal-directed benchmark the 100 highest scoring molecules in the dataset are selected as the initial population. During each epoch a mating pool of 200 molecules is sampled with replacement from the population, using scores as weights. This pool may contain many repeated specimens if their score is high. A new population of 100 is then generated by iteratively choosing two molecules at random from the mating pool and applying a crossover operation. With probability of 0.5 a mutation is also applied to the offspring molecule.
This process is repeated 1000 times or until progress has stopped for 5 consecutive epochs.
Graph MCTS
The MCTS molecule generation procedure follows the implementation by Jensen. 70 The statistics used during sampling are computed on the GuacaMol dataset.
For this baseline no initial population is selected for the goal-directed benchmarks. Following the author's parameters, each new molecule is generated by running 40 simulations, starting from a CC base molecule, at each step 25 children are considered and the roll-out stops when reaching 60 atoms. The best scoring molecule found during the roll-out is re-turned. A population of 100 molecules is generated at each epoch. This process is repeated 1000 times or until progress has stopped for 5 consecutive epochs.
For the distribution-learning benchmark the generation starts from a CC base molecule and a new molecule is generated with the same parameters as for the goal oriented, the only difference being that no scoring function is provided, so the first molecule to reach terminal state is returned instead.
SMILES LSTM
The SMILES LSTM is a simple, yet powerful baseline model, consisting of a long-short term memory (LSTM) 71 neural network which predicts the next character character of partial SMILES strings. 9 Combined with a simple hill-climb algorithm for optimization, it has recently been shown to perform as well as more sophisticated reinforcement learning algorithms such as proximal policy optimization (PPO) or advantage actor critic (A2C).
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The model used was an LSTM with 3 layers of hidden size of 1024. For the goal-directed benchmarks 20 iterations of hill-climbing were performed, at each step the model generated 8192 molecules and the top scoring 1024 were used to fine-tune the model parameters. For the distribution-learning benchmarks no fine tuning was done, the model simply generated the requested number of molecules.
Results and Discussion
Distribution-learning benchmarks Goal-directed benchmarks Table 3 However, especially for the similarity tasks, it scores lower than the Graph GA. The SMILES LSTM model nearly performs as well as the Graph GA model, and outperforms it on two benchmarks. The Graph MCTS model performs worse than the baseline selecting the best candidates from ChEMBL. 
Conclusions and Outlook
Recently, generative models for de novo molecular design based on neural networks have been introduced, and have shown promising results. However, there has been a lack of consistency in the evaluation of such models. The present work addressed this problem by introducing GuacaMol, a framework to quantitatively benchmark models for de novo design. It aims to provide a standardized way of assessing new models, and to improve comparability of the models.
Our framework defines two evaluation dimensions. First, it assesses models for their ability to learn from a dataset of molecules and to generate novel molecules with similar properties. Second, it evaluates the faculty of generative models to deliver molecules with specific properties, which we encode as molecule scores.
We provided a suite of benchmarks compatible with the evaluation framework. It encompasses a wide range of tasks, designed to assess the flexibility of generative models. The proposed suite comprises 5 benchmarks for the ability of generative models to learn distri-butions of molecules, and 20 optimization benchmarks for the generation of molecules with specific properties.
We evaluated a series of diverse baseline models. In terms of optimization performance, the best model is a genetic algorithm based on a graph representation of molecules. The second best model is a recurrent neural network model that considers SMILES representations of molecules. Both models achieve similar scores, which indicates that deep learning models can reach the performance of gold-standard discrete algorithms for de novo molecular design.
The evaluation of the proposed benchmark suite for the baseline models pointed out that some benchmark tasks can be too easily solved by most of the models. This indicates the necessity of harder tasks for benchmarking models for de novo molecular design in the future.
An important aspect that will need further focus is the quality of the generated molecules, which is difficult to measure objectively. Early results indicate that generative models pretrained on large datasets suffer less than genetic algorithms from the problem of generating unreasonable molecules. Furthermore, depending on the requirements, time constraints or sample efficiency of different models can become important, and will require further attention.
We are confident that the flexible open source framework presented herein will enable and inspire the community to come up with even more challenging benchmarks for de novo design, so that researchers can rigorously assess their models, and computational chemists can confidently harness models with well-understood strengths and limitations.
